| scholarly article | Q13442814 |
| P50 | author | Yagya D Sharma | Q122675130 |
| P2093 | author name string | Ashwani Kumar | |
| Anwar Ahmed | |||
| Vas Dev | |||
| Sumiti Vinayak | |||
| Sukla Biswas | |||
| Deepak Bararia | |||
| Mohammed Yameen | |||
| Musharraf A Ansari | |||
| P2860 | cites work | Insights into antifolate resistance from malarial DHFR-TS structures | Q27641016 |
| Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum | Q27861947 | ||
| Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia | Q30984906 | ||
| Current scenario of malaria in India. | Q33852240 | ||
| Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania | Q34885646 | ||
| The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum | Q35095240 | ||
| Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum | Q35618862 | ||
| Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase | Q35988728 | ||
| Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance | Q37739332 | ||
| Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria | Q37739425 | ||
| High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi. | Q38927563 | ||
| Antifolate antimalarial resistance in southeast Africa: a population-based analysis | Q39408064 | ||
| Prevalence of the K76T mutation in the pfcrt gene of Plasmodium falciparum among chloroquine responders in India | Q41915658 | ||
| Molecular survey of Plasmodium falciparum resistance in south-eastern Iran | Q41915746 | ||
| Analysis of pfcrt, pfmdr1, dhfr, and dhps mutations and drug sensitivities in Plasmodium falciparum isolates from patients in Vietnam before and after treatment with artemisinin | Q41916039 | ||
| High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations | Q41916249 | ||
| Molecular epidemiology of malaria in Cameroon. XII. In vitro drug assays and molecular surveillance of chloroquine and proguanil resistance. | Q41916606 | ||
| Genetics of drug-resistant Plasmodium falciparum malaria in the Venezuelan state of Bolivar | Q41916612 | ||
| Plasmodium falciparum dihydrofolate reductase Val-16 and Thr-108 mutation associated with in vivo resistance to antifolate drug: a case study | Q41917215 | ||
| Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study | Q41920911 | ||
| Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins | Q41927581 | ||
| Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya | Q41928091 | ||
| High prevalence of chloroquine resistant Plasmodium falciparum infection in Rajasthan epidemic | Q41929631 | ||
| Pyrimethamine and Proguanil Resistance-Conferring Mutations in Plasmodium falciparum Dihydrofolate Reductase: Polymerase Chain Reaction Methods for Surveillance in Africa | Q41933010 | ||
| A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum | Q41933285 | ||
| Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. | Q41934737 | ||
| Molecular analysis of DHFR and DHPS genes in P. falciparum clinical isolates from the Haut--Ogooué region in Gabon | Q43580758 | ||
| Short report: differences in dihydrofolate reductase but not dihydropteroate synthase alleles in Plasmodium falciparum isolates from geographically distinct areas in Malaysia | Q43652744 | ||
| Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria | Q43864384 | ||
| Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life | Q44012338 | ||
| Pyrimethamine/sulfadoxine combination in the treatment of uncomplicated falciparum malaria: relation between dihydropteroate synthase/dihydrofolate reductase genotypes, sulfadoxine plasma levels, and treatment outcome | Q44199461 | ||
| Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance | Q44213203 | ||
| Rapid and simple method for isolating malaria DNA from fingerprick samples of blood | Q44230866 | ||
| Molecular assays for surveillance of antifolate-resistant malaria | Q45141285 | ||
| Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea | Q46340740 | ||
| The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya | Q46614362 | ||
| Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance | Q46878245 | ||
| Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum | Q48003670 | ||
| Plasmodium falciparum: mutation pattern in the dihydrofolate reductase-thymidylate synthase genes of Vietnamese isolates, a novel mutation, and coexistence of two clones in a Thai patient | Q48033279 | ||
| Plasmodium falciparum: detection of antifolate resistance by mutation-specific restriction enzyme digestion. | Q54173614 | ||
| Plasmodium falciparum: rapid detection of dihydrofolate reductase mutations that confer resistance to cycloguanil and pyrimethamine. | Q54269130 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | India | Q668 |
| Plasmodium falciparum | Q311383 | ||
| pyrimethamine | Q421072 | ||
| P304 | page(s) | 879-889 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance | |
| P478 | volume | 48 |
| Q37053376 | A clinical and molecular study of artesunate + sulphadoxine-pyrimethamine in three districts of central and eastern India |
| Q37153071 | A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan |
| Q41944114 | A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance |
| Q33879484 | A rare case of quadruple malaria infection from the highly malaria-endemic area of Bastar, Chhattisgarh, India. |
| Q34256119 | Analysis of polymorphisms in Plasmodium falciparum genes related to drug resistance: a survey over four decades under different treatment policies in Brazil |
| Q37726201 | Antimalarial drug policy in India: past, present & future |
| Q35955433 | Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in India |
| Q37450805 | Characteristics of genetic hitchhiking around dihydrofolate reductase gene associated with pyrimethamine resistance in Plasmodium falciparum isolates from India |
| Q28125942 | Characterization of drug resistance associated genetic polymorphisms among Plasmodium falciparum field isolates in Ujjain, Madhya Pradesh, India |
| Q37276724 | Chloroquine and sulphadoxine-pyrimethamine sensitivity of Plasmodium falciparum parasites in a Brazilian endemic area |
| Q47995484 | Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014. |
| Q28125932 | Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction |
| Q35941354 | Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India |
| Q36469382 | Current opinion on an emergence of drug resistant strains of Plasmodium falciparum through genetic alterations |
| Q64949660 | Development and Evaluation of a Novel HNB Based Isothermal Amplification Assay for Fast Detection of Pyrimethamine Resistance (S108N) in Plasmodium falciparum. |
| Q40981118 | Disagreement in genotyping results of drug resistance alleles of the Plasmodium falciparum dihydrofolate reductase (Pfdhfr) gene by allele-specific PCR (ASPCR) assays and Sanger sequencing. |
| Q41927173 | Discordance in drug resistance-associated mutation patterns in marker genes of Plasmodium falciparum and Plasmodium knowlesi during coinfections |
| Q35129708 | Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania |
| Q33676392 | Evidence of selective sweeps in genes conferring resistance to chloroquine and pyrimethamine in Plasmodium falciparum isolates in India |
| Q36313166 | Extensive genetic diversity in the Plasmodium falciparum Na+/H+ exchanger 1 transporter protein implicated in quinine resistance |
| Q36809226 | Genetic Diversity of Dihydropteroate synthetase Gene (dhps) of Plasmodium vivax in Hormozgan Province, Iran |
| Q37093699 | Genetic polymorphisms associated with sulphadoxine-pyrimethamine drug resistance among Plasmodium falciparum field isolates in malaria endemic areas of Assam |
| Q36826719 | High prevalence of asymptomatic malaria in a tribal population in eastern India |
| Q36064289 | In vitro assessment of drug resistance in Plasmodium falciparum in five States of India. |
| Q37144859 | Low prevalence of dihydro folate reductase (dhfr) and dihydropteroate synthase (dhps) quadruple and quintuple mutant alleles associated with SP resistance in Plasmodium vivax isolates of West Bengal, India |
| Q28125911 | Molecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapy |
| Q36474415 | Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009-2010. |
| Q35005151 | Multiple origins of Plasmodium falciparum dihydropteroate synthetase mutant alleles associated with sulfadoxine resistance in India |
| Q44569423 | New insights into the evolutionary history of Plasmodium falciparum from mitochondrial genome sequence analyses of Indian isolates |
| Q38939941 | No Polymorphism in Plasmodium falciparum K13 Propeller Gene in Clinical Isolates from Kolkata, India |
| Q38962481 | Novel quadruple mutations in dihydropteroate synthase genes of Plasmodium falciparum in West Bengal, India |
| Q28125924 | Polymorphism in drug resistance genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium falciparum in some states of India |
| Q36715542 | Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan |
| Q34826216 | Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal |
| Q39310650 | Prevalence of mutation and phenotypic expression associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum and Plasmodium vivax |
| Q36407073 | Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran |
| Q35127900 | Prevalence of mutations associated with higher levels of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Car Nicobar Island and Assam, India |
| Q47107010 | Prevalence of mutations linked to antimalarial resistance in Plasmodium falciparum from Chhattisgarh, Central India: A malaria elimination point of view |
| Q34569732 | Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan |
| Q35220888 | Pyrosequencing, a high-throughput method for detecting single nucleotide polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum |
| Q34510688 | Quadruple mutations in dihydrofolate reductase of Plasmodium falciparum isolates from Car Nicobar Island, India |
| Q43564389 | Ribozyme cleavage of Plasmodium falciparum gyrase A gene transcript affects the parasite growth |
| Q35647659 | Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum |
| Q37220079 | Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India |
| Q41945793 | Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern |
Search more.